Mexico Antibiotics Market Size & Outlook, 2023-2030
Mexico antibiotics market, 2018-2030 (US$M)
Related Markets
Mexico antibiotics market highlights
- The Mexico antibiotics market generated a revenue of USD 387.7 million in 2023 and is expected to reach USD 552.7 million by 2030.
- The Mexico market is expected to grow at a CAGR of 5.2% from 2024 to 2030.
- In terms of segment, cell wall synthesis inhibitors was the largest revenue generating action mechanism in 2023.
- DNA Synthesis Inhibitors is the most lucrative action mechanism segment registering the fastest growth during the forecast period.
Antibiotics market data book summary
| Market revenue in 2023 | USD 387.7 million |
| Market revenue in 2030 | USD 552.7 million |
| Growth rate | 5.2% (CAGR from 2023 to 2030) |
| Largest segment | Cell wall synthesis inhibitors |
| Fastest growing segment | DNA Synthesis Inhibitors |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors |
| Key market players worldwide | AbbVie Inc, Pfizer Inc, Novartis AG ADR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Lupin, Viatris Inc, Melinta Therapeutics, Cipla Ltd DR, Shionogi & Co Ltd, GSK PLC, Kyorin Pharmaceutical, Nabriva Therapeutics |
Other key industry trends
- In terms of revenue, Mexico accounted for 0.8% of the global antibiotics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil antibiotics market is projected to lead the regional market in terms of revenue in 2030.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 273.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antibiotics Market Scope
Antibiotics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico antibiotics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antibiotics market will help companies and investors design strategic landscapes.
Cell wall synthesis inhibitors was the largest segment with a revenue share of 47.25% in 2023. Horizon Databook has segmented the Mexico antibiotics market based on cell wall synthesis inhibitors, protein synthesis inhibitors, dna synthesis inhibitors, rna synthesis inhibitors, mycolic acid inhibitors covering the revenue growth of each sub-segment from 2018 to 2030.
- Mexico Antibiotics Action Mechanism Outlook (Revenue, USD Million, 2018-2030)
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
- Mexico Antibiotics Type Outlook (Revenue, USD Million, 2018-2030)
- Branded Antibiotics
- Generic Antibiotics
- Mexico Antibiotics Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Cephalosporins
- Penicillins
- Fluoroquinolones
- Macrolides
- Carbapenems
- Aminoglycosides
- Sulfonamides
- 7-ACA
- Others
Reasons to subscribe to Mexico antibiotics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico antibiotics market databook
-
Our clientele includes a mix of antibiotics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico antibiotics market , including forecasts for subscribers. This country databook contains high-level insights into Mexico antibiotics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico antibiotics market size, by action mechanism, 2018-2030 (US$M)
Mexico Antibiotics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
